| Original language | English (US) |
|---|---|
| Pages (from-to) | 19-22 |
| Number of pages | 4 |
| Journal | Controlled clinical trials |
| Volume | 9 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1988 |
ASJC Scopus subject areas
- Pharmacology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Controlled clinical trials, Vol. 9, No. 1, 03.1988, p. 19-22.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Report from a workshop
T2 - Archives for data and documents from completed clinical trials
AU - Hawkins, Barbara S.
AU - Gannon, Clara
AU - Hosking, James D.
AU - James, Kenneth E.
AU - Markowitz, Jan A.
AU - Mowery, Richard L.
N1 - Funding Information: Data Repositories During presentationo f survey findings (which are being prepart.i for pub lication), Dr. Markowitz noted that coordinating centersh ad served as the repository for data from a number of completedt rials, and Dr. James stated that in the VA Cooperative Studies Program, the coordinating centersp ro-vided that service. However, it was pointed out that such an arrangement was feasibleo nly when the facility housing the coordinatingc enterw itscertain to be maintained beyond the life of a specifict rial. Although it was suggested that the Societyf or Clinical Trials establisha suitabler epositoryf or documents from completedt rials, such a solution appearedu nlikely in the near future, Severali nvestigatorsp referredt o use IocaIi nstitutional librariesf or archiving; however, thereh as beeni nsufficient experiencet o evaluateo verallsatisfaction with such an approach. The NTIS provides the longevity that many coordinatingc entersc ouId not guarantee,b ut it was noted by Ms. Gannon thatN TIS acceptedo nly material from federally sponsored projects. This restriction prevented investigators participating in chnicnl trials sponsoredb y the pharmaceuticailn dustry, pri-vate foundations, or other nonfederals ourcesf rom using that repository.M S. Gannnn &ted that it might be possible for NTIS to accepti nformation from any clinical trial, regardlesso f sourceo f funding, by speciala rrangementw ith the Society for Clinical Trials. It was noted during the discussion that archived data probably were not used as frequently as they might be simply becausei nvestigatorsw ho might be interestedw ere unaware that such data had been placedi n an accessible repository. Investigatorsf rom severals tudies had published announcements of availability of archived materialsi n specialtyj ournals. Ms. Gannon men-tioned that NTIS had prepared brochurest o promote sales of materialso n specific topics that were on file at NTIS. She statedt hat NTIS staff probably would be willing to prepare a brochure devoted specificallyt o dxuments from clinical trials, but in order for such a brochure to be complete,i nvesti-gators who deposited information with NTIS must indicate that the items filed came from a clinical trial. A task for the Societyf or Clinical Trials would be to develop a recommendeds et of keywords that representv arious clinical trial topics to be used in documentationr equired of investigatorsw ho file materialsa t NTIS,
PY - 1988/3
Y1 - 1988/3
UR - http://www.scopus.com/inward/record.url?scp=0023911153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023911153&partnerID=8YFLogxK
U2 - 10.1016/0197-2456(88)90005-0
DO - 10.1016/0197-2456(88)90005-0
M3 - Article
C2 - 3356150
AN - SCOPUS:0023911153
SN - 0197-2456
VL - 9
SP - 19
EP - 22
JO - Controlled clinical trials
JF - Controlled clinical trials
IS - 1
ER -